Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan flag Japan · Delayed Price · Currency is JPY
2,412.00
+36.50 (1.54%)
Mar 27, 2026, 3:30 PM JST

Rohto Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
536,778505,369676,888631,946421,488336,849
Market Cap Growth
9.44%-25.34%7.11%49.93%25.13%-0.24%
Enterprise Value
531,869493,570610,616575,682380,505296,984
Last Close Price
2375.502218.102904.202690.131778.181407.26
PE Ratio
15.9916.3021.8823.9620.0520.12
Forward PE
16.1215.1920.0824.1519.9421.85
PS Ratio
1.601.642.502.652.111.86
PB Ratio
1.761.862.742.942.292.15
P/TBV Ratio
2.602.482.863.162.492.27
P/FCF Ratio
-18.1625.7728.1524.8229.84
P/OCF Ratio
-13.6919.7720.4315.4716.84
PEG Ratio
4.484.004.004.004.004.00
EV/Sales Ratio
1.581.602.262.411.911.64
EV/EBITDA Ratio
9.359.5612.5013.9310.6110.38
EV/EBIT Ratio
13.1712.8315.2017.1713.5013.58
EV/FCF Ratio
-17.7323.2525.6422.4126.31
Debt / Equity Ratio
0.170.190.040.050.120.05
Debt / EBITDA Ratio
0.920.970.210.280.600.28
Debt / FCF Ratio
-1.800.400.521.260.72
Net Debt / Equity Ratio
-0.07-0.10-0.32-0.32-0.28-0.29
Net Debt / EBITDA Ratio
-0.39-0.52-1.61-1.65-1.43-1.57
Net Debt / FCF Ratio
--0.97-3.00-3.04-3.03-3.97
Asset Turnover
0.780.800.830.820.800.82
Inventory Turnover
2.312.472.592.722.712.55
Quick Ratio
1.351.551.821.751.741.79
Current Ratio
2.032.302.472.372.302.36
Return on Equity (ROE)
12.20%11.94%13.59%13.25%12.42%11.31%
Return on Assets (ROA)
5.80%6.26%7.66%7.17%7.04%6.20%
Return on Invested Capital (ROIC)
11.04%13.63%19.28%18.52%17.47%14.91%
Return on Capital Employed (ROCE)
11.40%11.80%15.50%14.60%13.90%12.90%
Earnings Yield
6.43%6.13%4.57%4.17%4.99%4.97%
FCF Yield
-5.51%3.88%3.55%4.03%3.35%
Dividend Yield
1.93%1.62%0.93%0.82%1.01%1.00%
Payout Ratio
-22.81%17.70%17.73%16.28%17.71%
Buyback Yield / Dilution
-1.58%-0.04%0.00%0.00%--0.01%
Total Shareholder Return
0.36%1.58%0.93%0.82%1.01%0.99%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.